Wilson Sonsini Tops Life Sciences Law Firm Index For 2nd Straight Year
The Life Sciences Law Firm Index identifies the most active and relevant firms for life science companies.
Finding A Way Through A Tight Deal Space
Leaders of WilmerHale’s life sciences practice share trends they see regarding acquisitions and initial public offerings.
Why Experience Still Matters In An AI-Driven Legal Industry
A conversation with Trustpoint.One CEO Christopher Gallagher.
Navigating The Life Science M&A Savannah
What does the market for life sciences M&A look like right now?
Collaboration At Fenwick & West Steers Firm Through Complex Deals
What does the market for life sciences companies look like right now?
Newly United Arnold & Porter Kaye Scholer Surveys Changed Life Sciences Deal Environment
Experts offer their takes on the developing dealmaking environment in the early days of the Trump Administration.
Life Sciences Law Firm Index: Thought Leadership Category Update
This update recognizes the top firms in the Thought Leadership category of the Life Sciences Law Firm Index.
AI Is Reshaping Legal Practice—But Tools Aren’t The Real Differentiator.
Explore the mindset, cultural shifts, and training strategies that define the AI‑savvy lawyer, revealing why human judgment, standardized competence, and integrated learning—not technology alone—will shape the future of the profession.
Developing The Story Of Patent Litigation: Q&A With Cooley’s Ellen Scordino
This Biglaw partner brings pharma experience to law firm cases.
The Personal Touch In Patent Prosecution
When it comes to fighting disease, Fenwick & West partner Michael Shuster takes things personally.
Aggregate Spend Goes Global
As states began to jump onto the pharmaceutical regulation bandwagon around the turn of the century, Porzio Bromberg & Newman brought John Ohoro on to help clients sift through the growing maze of rules and regulations across the U.S.